IMAX Corp. (IMAX) Misses Q1 EPS by 34c, Revenues Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/1/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
- Qualcomm shares fall on Intel warning and legal concerns
- Marvell Technology shares drop on Lumentum deal concerns
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Oracle shares drop on AI spending concerns and Microsoft criticism
- SpaceX stock drops on launch setback and sector selloff
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
- After-Hours Movers: WDC, BE, DECK, FIX, RNG
Pre-Open Movers 04/28: (IBIO) (RTIX) (FFIV) Higher; (NBES) (HLIT) (GAIA) Lower (more...)
April 28, 2020 9:27 AM EDTToday's Pre-Open Stock Movers
iBio, Inc. (NYSE: IBIO) 50% HIGHER; provided an update on its COVID-19 vaccine manufacturing capacity and announced that it has joined the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), one of 14 institutes in the Manufacturing USA Network.
RTI Surgical Holdings, Inc. (Nasdaq: RTIX) 29.9% HIGHER; announces a second amendment to its definitive agreement for the sale of RTI Surgical Holdings' OEM business to Montagu Private Equity LLP. Reduces the cash purchase price from $480,000,000 to... More
Benchmark Upgrades IMAX Corporation (IMAX) to Buy; Optimistic on Long-Term
April 28, 2020 5:59 AM EDT(Updated - April 28, 2020 8:12 AM EDT)
(updated to add analyst comments)
Benchmark analyst Mike Hickey upgraded IMAX Corporation (NYSE: IMAX) from Hold to Buy with a $14 price target.
The analyst commented, "We are upgrading IMAX to Buy with a $14 price target. We are optimistic that over... More



